Citations (13)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (3)
Mehdi Dehghani, Ali Kashkooe, Nasrin Namdari, Reza Majidi, Mojtaba Karimi, Shirin Haghighat, Alireza Rezvani & Negar Safari. (2023) Long-term follow-up of patients with hairy cell leukemia in the south of Iran. Expert Review of Hematology 16:4, pages 289-295.
Read now
Read now
Qiuying Liu, Nicholas Harris, Narendranath Epperla & Leslie A Andritsos. (2021) Current and Emerging Therapeutic Options for Hairy Cell Leukemia Variant. OncoTargets and Therapy 14, pages 1797-1805.
Read now
Read now
Tadeusz Robak, Anna Wolska & Pawel Robak. (2015) Potential breakthroughs with investigational drugs for hairy cell leukemia. Expert Opinion on Investigational Drugs 24:11, pages 1419-1431.
Read now
Read now
Articles from other publishers (10)
Farhad Ravandi, Robert J. Kreitman, Enrico Tiacci, Leslie Andritsos, Versha Banerji, Jacqueline C. Barrientos, Seema A. Bhat, James S. Blachly, Alessandro Broccoli, Timothy Call, Dai Chihara, Claire Dearden, Judit Demeter, Sasha Dietrich, Monica Else, Narendranath Epperla, Brunangelo Falini, Francesco Forconi, Douglas E. Gladstone, Alessandro Gozzetti, Sunil Iyengar, James B. Johnston, Jeffrey Jorgensen, Gunnar Juliusson, Francesco Lauria, Gerard Lozanski, Sameer A. Parikh, Jae H. Park, Aaron Polliack, Graeme Quest, Tadeusz Robak, Kerry A. Rogers, Alan Saven, John F. Seymour, Tamar Tadmor, Martin S. Tallman, Constantine S. Tam, Philip A. Thompson, Xavier Troussard, Clive S. Zent, Thorsten Zenz, Pier Luigi Zinzani, Bernhard Wörmann, Kanti Rai & Michael Grever. (2022) Consensus opinion from an international group of experts on measurable residual disease in hairy cell leukemia. Blood Cancer Journal 12:12.
Crossref
Crossref
Xavier Troussard, Elsa Maître & Edouard Cornet. (2021) Hairy cell leukemia 2022: Update on diagnosis, risk‐stratification, and treatment. American Journal of Hematology 97:2, pages 226-236.
Crossref
Crossref
Olivera Markovic, Mirjana Gotic, Vesna Cemerikic, Anica Divac & Dragomir Marisavljevic. (2022) Successful treatment of synchronous hairy cell leukaemia and diffuse large B cell lymphoma in a patient with severe hypercalcemia and extensive osteolytic lesions. Vojnosanitetski pregled Military Medical and Pharmaceutical Journal of Serbia 79:10, pages 1044-1047.
Crossref
Crossref
Nilima Parry‐Jones, Anurag Joshi, Francesco Forconi & Claire Dearden. (2020) Guideline for diagnosis and management of hairy cell leukaemia (HCL) and hairy cell variant (HCL‐V). British Journal of Haematology 191:5, pages 730-737.
Crossref
Crossref
Ahmed Fawzy Okba. (2020) Hairy Cell Leukemia – A Mortality Analysis. Journal of Insurance Medicine 48:2, pages 136-143.
Crossref
Crossref
Elsa Maitre, Edouard Cornet & Xavier Troussard. (2019) Hairy cell leukemia: 2020 update on diagnosis, risk stratification, and treatment. American Journal of Hematology 94:12, pages 1413-1422.
Crossref
Crossref
Francine Garnache Ottou, Marie-Olivia Chandesris, Ludovic Lhermitte, Céline Callens, Kheira Beldjord, Marlene Garrido, Anne-Sophie Bedin, Chantal Brouzes, Sarah Villemant, Marie-Thérèse Rubio, Coralie Belanger, Felipe Suarez, Bénédicte Deau, François Lefrère, Olivier Hermine, Vahid Asnafi, Bruno Varet & Elizabeth Macintyre. (2014) Peripheral blood 8 colour flow cytometry monitoring of hairy cell leukaemia allows detection of high-risk patients. British Journal of Haematology 166:1, pages 50-59.
Crossref
Crossref
V Maevis, U Mey, G Schmidt-Wolf & I G H Schmidt-Wolf. (2014) Hairy cell leukemia: short review, today’s recommendations and outlook. Blood Cancer Journal 4:2, pages e184-e184.
Crossref
Crossref
Rekha Chandran, Stuart K. Gardiner, Stephen D. Smith & Stephen E. Spurgeon. (2013) Improved survival in hairy cell leukaemia over three decades: a SEER database analysis of prognostic factors. British Journal of Haematology 163:3, pages 407-409.
Crossref
Crossref
Farhad Ravandi, Susan O'Brien, Jeffrey Jorgensen, Sherry Pierce, Stefan Faderl, Alessandra Ferrajoli, Charles Koller, Pramoda Challagundla, Sergernne York, Mark Brandt, Rajyalakshmi Luthra, Jan Burger, Deborah Thomas, Michael Keating & Hagop Kantarjian. (2011) Phase 2 study of cladribine followed by rituximab in patients with hairy cell leukemia. Blood 118:14, pages 3818-3823.
Crossref
Crossref